Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Jagust

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Acta Neuropathologica Communications|March 8, 2014
Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognitionJon B Toledo, Michael W Weiner, David A Wolk, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 28, 2023
A robust harmonization approach for cognitive data from multiple aging and dementia cohortsJoseph Giorgio, Ankeet Tanna, Maura Malpetti, et al.
Alzheimer Disease and Associated Disorders|May 28, 2025
Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)José A Luchsinger, Davangere Devanand, Terry E Goldberg, et al.
Nature Communications|August 26, 2025
Distinct manifestations of excitatory-inhibitory imbalance associated with amyloid-β and tau in patients with Alzheimer's diseaseKamalini G Ranasinghe, Kiwamu Kudo, Faatimah Syed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal dataMark E Schmidt, Ping Chiao, Gregory Klein, et al.
Neurobiology of Aging|September 27, 2016
Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET studyClaudio Babiloni, Claudio Del Percio, Anna Caroli, et al.
Acta Neuropathologica|August 2, 2011
Factors affecting Aβ plasma levels and their utility as biomarkers in ADNIJon B Toledo, Hugo Vanderstichele, Michal Figurski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2018
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging InitiativeDallas P Veitch, Michael W Weiner, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2017
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trialsMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Nature Reviews. Neurology|January 20, 2016
Suspected non-Alzheimer disease pathophysiology--concept and controversyClifford R Jack, David S Knopman, Gaël Chételat, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Acta Neuropathologica Communications|March 8, 2014
Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognitionJon B Toledo, Michael W Weiner, David A Wolk, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 28, 2023
A robust harmonization approach for cognitive data from multiple aging and dementia cohortsJoseph Giorgio, Ankeet Tanna, Maura Malpetti, et al.
Alzheimer Disease and Associated Disorders|May 28, 2025
Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)José A Luchsinger, Davangere Devanand, Terry E Goldberg, et al.
Nature Communications|August 26, 2025
Distinct manifestations of excitatory-inhibitory imbalance associated with amyloid-β and tau in patients with Alzheimer's diseaseKamalini G Ranasinghe, Kiwamu Kudo, Faatimah Syed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal dataMark E Schmidt, Ping Chiao, Gregory Klein, et al.
Neurobiology of Aging|September 27, 2016
Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET studyClaudio Babiloni, Claudio Del Percio, Anna Caroli, et al.
Acta Neuropathologica|August 2, 2011
Factors affecting Aβ plasma levels and their utility as biomarkers in ADNIJon B Toledo, Hugo Vanderstichele, Michal Figurski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2018
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging InitiativeDallas P Veitch, Michael W Weiner, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2017
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trialsMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Nature Reviews. Neurology|January 20, 2016
Suspected non-Alzheimer disease pathophysiology--concept and controversyClifford R Jack, David S Knopman, Gaël Chételat, et al.
Pageof 10